Cargando…
Assessment of Clinical Profile and Treatment Outcome in Vaccinated and Unvaccinated SARS-CoV-2 Infected Patients
Vaccines against severe acute respiratory syndrome-corona virus-2 (SARS-CoV-2) infection, which causes coronavirus disease–19 (COVID-19) in humans, have been developed and are being tested for safety and efficacy. We conducted the cross-sectional prospective cohort study on 820 patients who were pos...
Autores principales: | Korishettar, Ganesh, Chikkahonnaiah, Prashanth, Tulimilli, SubbaRao V., Dallavalasa, Siva, Byrappa, Shashidhar H., Madhunapantula, SubbaRao V., Veeranna, Ravindra P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321523/ https://www.ncbi.nlm.nih.gov/pubmed/35891289 http://dx.doi.org/10.3390/vaccines10071125 |
Ejemplares similares
-
Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Vaccine Effectiveness
por: Tulimilli, SubbaRao V., et al.
Publicado: (2022) -
COVID-19: Diabetes Perspective—Pathophysiology and Management
por: Dallavalasa, Siva, et al.
Publicado: (2023) -
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2)
por: Beeraka, Narasimha M., et al.
Publicado: (2021) -
Vitamin D3 Inhibits the Viability of Breast Cancer Cells In Vitro and Ehrlich Ascites Carcinomas in Mice by Promoting Apoptosis and Cell Cycle Arrest and by Impeding Tumor Angiogenesis
por: Veeresh, Prashanth Kumar M., et al.
Publicado: (2023) -
Therapeutic Implications of Targeting AKT Signaling in Melanoma
por: Madhunapantula, SubbaRao V., et al.
Publicado: (2011)